OneMedNet Stockholders Approve Reverse Split and 1M Share Equity Plan Increase
ONMD sits 33% above its 52-week low of $0.49 on light trading volume (0.2× avg).
Summary
OneMedNet's 2026 Annual Meeting approved a reverse stock split (up to 1-for-20), a 1M share increase to its equity plan, and elected three Class III directors. The board later set the reverse split ratio at 1-for-10, effective September 29.
Updated with a GlobeNewswire report · What changed
Updates
· SEC 8-K — The 8-K confirms the reverse split, reducing outstanding shares from about 60.13M to 6.01M as of Sept. 27, with new CUSIP 68270C 202.
· GlobeNewswire — Board set the reverse split ratio at 1-for-10, effective Sept. 29, reducing shares from about 59.29M to 5.93M.
Key Events · Corporate Governance and Compliance · ONMD
-
Updated · · GlobeNewswire
Reverse Split Approved and Ratio Set
Stockholders approved a reverse split at a ratio between 1-for-5 and 1-for-20, with the board authorized to choose the exact ratio. Vote: 41,068,200 for, 739,329 against. The board later set the ratio at 1-for-10, effective September 29, reducing shares from about 59.29 million to 5.93 million.
-
Equity Plan Share Increase
The 2022 Equity Incentive Plan reserve was increased by 1,000,000 shares, effective immediately upon stockholder approval.
-
Director Elections
Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu were elected as Class III directors for three-year terms expiring at the 2029 Annual Meeting.
-
Auditor Ratified
WithumSmith+Brown, PC was ratified as the independent registered public accounting firm for the year ending December 31, 2026.
Analysis · ONMD · Industrial Applications And Services
OneMedNet stockholders approved a reverse stock split of up to 1-for-20, giving the board discretion to execute it to regain Nasdaq compliance. The board subsequently set the ratio at 1-for-10, effective September 29, reducing shares from about 59.29 million to 5.93 million. The vote also added 1 million shares to the equity incentive plan, creating modest additional dilution potential. The reverse split approval is the key event — it is the mechanism the company will likely use to lift its share price above the $1.00 minimum bid requirement, but it does not by itself change the company's fundamentals or cash position.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ONMD was trading at $0.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $38.8M. The 52-week trading range was $0.49 to $4.22. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.